𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

✍ Scribed by Martin Schaefer; Folkhard Schmidt; Christian Folwaczny; Reinhard Lorenz; Gaby Martin; Norbert Schindlbeck; Walter Heldwein; Michael Soyka; Heinz Grunze; August Koenig; Klaus Loeschke

Book ID
111722099
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
113 KB
Volume
37
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis C treatment in β€œdifficult-to-t
Hepatitis C treatment in β€œdifficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat

Risk factors for infection during treatm
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C
✍ Robert Roomer; Bettina E. Hansen; Harry L. A. Janssen; Robert J. de Knegt πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Neutropenia during treatment with peginterferon alfa and ribavirin for chronic hepatitis C virus (HCV) infection is a common cause of dose reductions of peginterferon alfa. These reductions are performed to prevent bacterial and fungal infections, which are common during HCV treatment and can be att